Shanghai, China – On May 4, ShanghaiMicroPort EP MedTech Co., Ltd. (“MicroPort EP”) obtained the registrationcertificates of Brazil ANVISA for its developed OptimAblate™ Cardiac RFGenerator, OptimAblate™ Irrigation Pump and OptimAblate™ Tubing Set.
The OptimAblate™ Cardiac RF Generator isdesigned for cardiac RF ablation surgery, and it is used by connecting with anablation catheter and a neutral electrode plate to form a circuit, achieving RFenergy transmission. OptimAblate™ Irrigation Pump is a kind of peristaltic pumpintended for delivering perfusate to the irrigation catheter throughOptimAblate™ Tubing Set. It has double flow velocity function, which is to beable to switch infusion speed between high and low flow rate. The Brazil ANVISAapproval means a full range of electrophysiological products will soon enterthe Brazil market and lay a great foundation for MicroPort EP to furtherexpand the South American market. In the future, MicroPort EP will continue todeeply explore the Brazilian and South American markets to provide the localpatients and doctors with integrated electrophysiological solutions of highquality and accessibility.